Cargando…

P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP.

Detalles Bibliográficos
Autores principales:	Garcia-Guiñon, Antonio, Andrea Charry, Paola, Moraima Jimenez, Maria, Sarra Escarre, Jose, Delgado, Izarbe, de la Torre, Laura Segura, Santaliestra Tomas, Marta, Garcia Pintos, Marta, Gonzalez Montes, Yolanda, Magan, Maria Alicia Senin, Motllo, Cristina, Ben Azaiz, Randa, Elena Cabezudo, Maria, Granell Gorrochategui, Miquel, Sancho, Esther, Jose Herranz, Maria, Seres, Yasmina, Gironella, Mercedes, Soler, Juan A, Tutusaus, Jose Maria Marti, Abella Monreal, Eugenia, Fernandez de Larrea, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431517/ http://dx.doi.org/10.1097/01.HS9.0000970652.81324.da

Ejemplares similares

Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd)
por: Byun, Ja Min, et al.
Publicado: (2020)

Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma
por: Tan, Carlyn Rose, et al.
Publicado: (2023)

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
por: Tan, Carlyn Rose, et al.
Publicado: (2023)

Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2020)

Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
por: Leypoldt, Lisa B., et al.
Publicado: (2021)

Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE study
por: Dimopoulos, Meletios, et al.
Publicado: (2018)

P893: CARFILZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (KRD) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS: ITALIAN, MULTICENTER, RETROSPECTIVE EXPERIENCE OUTSIDE OF CLINICAL TRIALS
por: Martino, E. A., et al.
Publicado: (2022)

Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara‐KRd), autologous hematopoietic cell transplantation, and measurable residual disease‐response‐adapted treatment cessation
por: Silbermann, Rebecca W., et al.
Publicado: (2023)

Protective Effect of Glycomacropeptide on the Inflammatory Response of U937 Macrophages
por: Córdova-Dávalos, Laura Elena, et al.
Publicado: (2023)

URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia
por: Demartini, Chiara, et al.
Publicado: (2023)

Rapid Plant Invasion in Distinct Climates Involves Different Sources of Phenotypic Variation
por: Monty, Arnaud, et al.
Publicado: (2013)

P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)
por: Ludwig, Heinz, et al.
Publicado: (2023)

Respuesta al artículo prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores
por: Hernández Pérez, José María, et al.
Publicado: (2019)

Is the determination of C‐reactive protein really necessary in the diagnosis of Alpha‐1 antitrypsin deficiency?
por: Hernández‐Pérez, José María, et al.
Publicado: (2022)

Is there any kind of relationship between alpha-1 antitrypsin levels and lung function parameters?
por: Hernández-Pérez, José María, et al.
Publicado: (2023)

Detección de casos de déficit de alfa-1 antitripsina, ¿restringimos o ampliamos?
por: Hernández Pérez, José María, et al.
Publicado: (2023)

¿Puede ser la deficiencia de alfa-1 antitripsina un factor protector contra la hipertensión arterial y la cardiopatía isquémica?
por: Hernández Pérez, José María, et al.
Publicado: (2022)

Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review
por: Parrondo, Ricardo D., et al.
Publicado: (2020)

Draft Genome Sequence of Bacillus velezensis Strain Krd-20 with Antifungal Activity, a Biotechnologically Important Isolate from Wheat Root Zone
por: Kopyltsov, Sergey V., et al.
Publicado: (2022)

Interleukin-6 Released from Fibroblasts Is Essential for Up-regulation of Matrix Metalloproteinase-1 Expression by U937 Macrophages in Coculture: CROSS-TALKING BETWEEN FIBROBLASTS AND U937 MACROPHAGES EXPOSED TO HIGH GLUCOSE
por: Sundararaj, Kamala P., et al.
Publicado: (2009)

Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells
por: Baek, Young-Sook, et al.
Publicado: (2009)

Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement
por: Español, Ignacio, et al.
Publicado: (2017)

U937 variant cells as a model of apoptosis without cell disintegration
por: Stasiłojć, Grzegorz, et al.
Publicado: (2013)

Pneumocystis jirovecii in Spanish Patients With Heart Failure
por: Merino-Casallo, Izarbe, et al.
Publicado: (2019)

Data on the generation of two Nr2e3 mouse models by CRISPR / Cas9D10A nickase
por: Aísa-Marín, Izarbe, et al.
Publicado: (2020)

Quantifying Heterogeneity According to Deformation of the U937 Monocytes and U937-Differentiated Macrophages Using 3D Carbon Dielectrophoresis in Microfluidics
por: Elitas, Meltem, et al.
Publicado: (2020)

Inside the new building 937 at CERN Prévessin site
por: Ordan, Julien Marius
Publicado: (2021)

Effects of URB937 on an animal model of migraine pain
por: Greco, R, et al.
Publicado: (2013)

Reactive Oxygen Species Imaging in U937 Cells
por: Prasad, Ankush, et al.
Publicado: (2020)

Cytotoxicity of the Sesquiterpene Lactone Spiciformin and Its Acetyl Derivative against the Human Leukemia Cell Lines U-937 and HL-60
por: Saavedra, Ester, et al.
Publicado: (2020)

PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP)
por: Mele, A., et al.
Publicado: (2022)

Caboxamycin biosynthesis pathway and identification of novel benzoxazoles produced by cross‐talk in Streptomyces sp. NTK 937
por: Losada, Armando A., et al.
Publicado: (2017)

Effect of Lean Red Meat from Beef (Pirenaica Breed) Versus Lean White Meat Consumption on Diet Quality: A Randomized-Controlled Crossover Study in Healthy Young Adults
por: Miguel-Berges, Maria Luisa, et al.
Publicado: (2022)

Características de pacientes remitidos a la consulta de Neumología de un hospital de segundo nivel
por: Hernández Pérez, José María, et al.
Publicado: (2022)

Gallium-67 radiotoxicity in human U937 lymphoma cells.
por: Jonkhoff, A. R., et al.
Publicado: (1993)

Correction Lancet Respir Med 2022; 10: 937–48
Publicado: (2023)

Exposure of human lymphoma cells (U-937) to the action of a single mycotoxin as well as in mixtures with the potential protectors 24-epibrassinolide and selenium ions
por: Barbasz, Anna, et al.
Publicado: (2018)

Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma
por: Lutzky, Jose, et al.
Publicado: (2023)

Draft Genome Sequence of Marine Actinomycete Streptomyces sp. Strain NTK 937, Producer of the Benzoxazole Antibiotic Caboxamycin
por: Olano, Carlos, et al.
Publicado: (2014)

Astaxanthin Treatment Confers Protection against Oxidative Stress in U937 Cells Stimulated with Lipopolysaccharide Reducing O(2) (−) Production
por: Franceschelli, Sara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_utf27gj2saqvohpek8i5qkuj4f